Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Holdings Boosted by Kiltearn Partners LLP

Kiltearn Partners LLP grew its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.6% in the 4th quarter, Holdings Channel reports. The firm owned 1,010,000 shares of the pharmacy operator’s stock after acquiring an additional 112,900 shares during the quarter. Walgreens Boots Alliance comprises approximately 1.6% of Kiltearn Partners LLP’s holdings, making the stock its 25th biggest position. Kiltearn Partners LLP’s holdings in Walgreens Boots Alliance were worth $9,423,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Norges Bank bought a new stake in Walgreens Boots Alliance in the 4th quarter valued at about $58,241,000. NEOS Investment Management LLC increased its stake in shares of Walgreens Boots Alliance by 31.1% in the fourth quarter. NEOS Investment Management LLC now owns 41,986 shares of the pharmacy operator’s stock valued at $392,000 after purchasing an additional 9,952 shares during the period. UniSuper Management Pty Ltd raised its holdings in shares of Walgreens Boots Alliance by 14.6% during the fourth quarter. UniSuper Management Pty Ltd now owns 184,745 shares of the pharmacy operator’s stock valued at $1,724,000 after buying an additional 23,581 shares during the last quarter. Korea Investment CORP boosted its position in shares of Walgreens Boots Alliance by 20.3% during the fourth quarter. Korea Investment CORP now owns 292,227 shares of the pharmacy operator’s stock worth $2,726,000 after buying an additional 49,300 shares during the period. Finally, Modern Wealth Management LLC bought a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $129,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have weighed in on WBA. StockNews.com initiated coverage on Walgreens Boots Alliance in a research note on Wednesday. They set a “hold” rating on the stock. Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Finally, Royal Bank of Canada raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Trading Up 0.5 %

NASDAQ WBA opened at $11.16 on Friday. The firm’s 50 day moving average price is $10.86 and its two-hundred day moving average price is $9.88. The stock has a market cap of $9.64 billion, a price-to-earnings ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the prior year, the business earned $0.66 EPS. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.